Lilly Releases Zyprexa Long-Term Injectable Data

As part of its rehabilitation efforts for a drug the FDA didn't approve earlier this year, Lilly released a new set of data for its long-acting injectable today. I have nothing to add, except that I truly feel awful for anyone who ends up on this drug, which will likely be approved by the FDA at some point.